
United States · Hospital & health care startup
Wellinks is a digital health company based in New Haven, Connecticut, focused on enhancing cardiopulmonary care, particularly for individuals with Chronic Obstructive Pulmonary Disease (COPD).
Funding reportedLast round: Series C
Wellinks is a digital health company based in New Haven, Connecticut, focused on enhancing cardiopulmonary care, particularly for individuals with Chronic Obstructive Pulmonary Disease (COPD).
Founded in 2014, Wellinks offers an integrated virtual management system that combines technology, coaching, and real-time monitoring to improve patient outcomes and reduce healthcare costs. The company provides a range of virtual services, including guided pulmonary rehabilitation programs, personalized health coaching, and connected devices like the FDA-approved portable nebulizer, Flyp. Their patient app allows for diagnostic monitoring and communication with healthcare professionals. Wellinks also offers remote monitoring to track patient data continuously, providing valuable insights for healthcare providers. The company serves patients, healthcare providers, and payers, aiming to improve care and reduce costs in the management of chronic respiratory conditions.
Funding, as reported
From Wellinks's own website and the SEC filings it signed: 6 on the team.
On the board, as filediLevi Deluke
What they build
Known for
hardwarehealth caredigital healthconsumersai-driven risk detectionremote monitoring systemhealth outcome improvementcontinuous respiratory monitoringenterprisesvirtual pulmonary rehabilitationearly warning systemsspire360 platforminformation technology & serviceswearable respiratory sensorscost savingspatient engagement tools
Built with from their website
Google Tag ManagerAmazon CloudFrontAWS Trusted AdvisorAtlassianReact NativeLinkedin Insight TagClarity SDMKlaviyoGoogle WorkspaceCloudFlare
Viewport MetaLinkedIn AdsWebflow HostingApple Business ManagerCloudFlare CDNTwilio SendGrid Email Marketing CampaignsCAPTCHAGoogle Font API
Add your raise, your deck and your story, and put Wellinks in front of investors. Or tell us what we have wrong.